Literature DB >> 15619075

Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells.

R B Ceddia1, R Somwar, A Maida, X Fang, G Bikopoulos, G Sweeney.   

Abstract

AIMS/HYPOTHESIS: The aim of this study was to determine whether adiponectin elicits glucose uptake via increased GLUT4 translocation and to investigate the metabolic fate of glucose in skeletal muscle cells treated with globular adiponectin.
MATERIALS AND METHODS: Basal and insulin-stimulated 2-deoxy-D: -[(3)H]glucose uptake, cell surface myc-tagged GLUT4 content, production of (14)CO(2) by oxidation of D: -[U-(14)C]glucose and [1-(14)C]oleate, and incorporation of D: -[U-(14)C]glucose into glycogen and lactate were measured in the presence and absence of globular adiponectin.
RESULTS: RT-PCR and Western blot analysis revealed that L6 cells and rat skeletal muscle cells express AdipoR1 mRNA and protein. Globular adiponectin increased both GLUT4 translocation and glucose uptake by increasing the transport V(max) of glucose without altering the K(m). Interestingly, the incorporation of D: -[U-(14)C]glucose into glycogen under basal and insulin-stimulated conditions was significantly decreased by globular adiponectin, whereas lactate production was increased. Furthermore, globular adiponectin did not affect glucose oxidation, but enhanced phosphorylation of AMP kinase and acetyl-CoA carboxylase, and fatty acid oxidation. CONCLUSIONS/
INTERPRETATION: The present study is the first to show that globular adiponectin increases glucose uptake in skeletal muscle cells via GLUT4 translocation and subsequently reduces the rate of glycogen synthesis and shifts glucose metabolism toward lactate production. These effects are consistent with the increased phosphorylation of AMP kinase and acetyl-CoA carboxylase and oxidation of fatty acids induced by globular adiponectin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15619075     DOI: 10.1007/s00125-004-1609-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

Review 1.  Adiponectin: a regulator of energy homeostasis.

Authors:  George Wolf
Journal:  Nutr Rev       Date:  2003-08       Impact factor: 7.110

2.  The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase.

Authors:  D Carling; D G Hardie
Journal:  Biochim Biophys Acta       Date:  1989-06-15

Review 3.  ACRP30, a new hormone controlling fat and glucose metabolism.

Authors:  Tsu-Shuen Tsao; Harvey F Lodish; Joachim Fruebis
Journal:  Eur J Pharmacol       Date:  2002-04-12       Impact factor: 4.432

4.  Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.

Authors:  T P Combs; A H Berg; S Obici; P E Scherer; L Rossetti
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.

Authors:  R R Russell; R Bergeron; G I Shulman; L H Young
Journal:  Am J Physiol       Date:  1999-08

6.  AMPK beta subunit targets metabolic stress sensing to glycogen.

Authors:  Galina Polekhina; Abhilasha Gupta; Belinda J Michell; Bryce van Denderen; Sid Murthy; Susanne C Feil; Ian G Jennings; Duncan J Campbell; Lee A Witters; Michael W Parker; Bruce E Kemp; David Stapleton
Journal:  Curr Biol       Date:  2003-05-13       Impact factor: 10.834

7.  Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes.

Authors:  Xiangdong Wu; Hiroyuki Motoshima; Kalyankar Mahadev; Timothy J Stalker; Rosario Scalia; Barry J Goldstein
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

Review 8.  Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase.

Authors:  D Carling; L G D Fryer; A Woods; T Daniel; S L C Jarvie; H Whitrow
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

9.  Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis.

Authors:  Toshimasa Yamauchi; Junji Kamon; Hironori Waki; Yasushi Imai; Nobuhiro Shimozawa; Kyouji Hioki; Shoko Uchida; Yusuke Ito; Keisuke Takakuwa; Junji Matsui; Makoto Takata; Kazuhiro Eto; Yasuo Terauchi; Kajuro Komeda; Masaki Tsunoda; Koji Murakami; Yasuyuki Ohnishi; Takeshi Naitoh; Kenichi Yamamura; Yoshito Ueyama; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

10.  Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

Authors:  Hironori Waki; Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Shoko Uchida; Shunbun Kita; Kazuo Hara; Yusuke Hada; Francis Vasseur; Philippe Froguel; Satoshi Kimura; Ryozo Nagai; Takashi Kadowaki
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

View more
  80 in total

1.  Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/AKT insulin pathway.

Authors:  Xue-Qi Zeng; Chun-Mei Zhang; Mei-Ling Tong; Xia Chi; Xi-Ling Li; Chen-Bo Ji; Rong Zhang; Xi-Rong Guo
Journal:  J Bioenerg Biomembr       Date:  2012-04-18       Impact factor: 2.945

2.  Over-expression of LYRM1 inhibits glucose transport in rat skeletal muscles via attenuated phosphorylation of PI3K (p85) and Akt.

Authors:  Chunzhao Kou; Xinguo Cao; Dani Qin; Chenbo Ji; Jingai Zhu; Chunmei Zhang; Chun Zhu; Chunlin Gao; Ronghua Chen; Xirong Guo; Min Zhang
Journal:  Mol Cell Biochem       Date:  2010-11-12       Impact factor: 3.396

3.  Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal growth.

Authors:  Fredrick J Rosario; Michael A Schumacher; Jean Jiang; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

4.  Overexpression of PGC-1β improves insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes.

Authors:  Chun-Lin Gao; Guang-Ling Liu; Shi Liu; Xiao-Hui Chen; Chen-Bo Ji; Chun-Mei Zhang; Zheng-Kun Xia; Xi-Rong Guo
Journal:  Mol Cell Biochem       Date:  2011-04-16       Impact factor: 3.396

5.  Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding.

Authors:  Varsha Thakur; Michele T Pritchard; Megan R McMullen; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-12       Impact factor: 4.052

Review 6.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

7.  Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt.

Authors:  Chun-mei Zhang; Xiao-hui Chen; Bin Wang; Feng Liu; Xia Chi; Mei-ling Tong; Yu-hui Ni; Rong-hua Chen; Xi-rong Guo
Journal:  Acta Pharmacol Sin       Date:  2008-12-15       Impact factor: 6.150

8.  Metabolomic profiling in liver of adiponectin-knockout mice uncovers lysophospholipid metabolism as an important target of adiponectin action.

Authors:  Ying Liu; Sanjana Sen; Sivaporn Wannaiampikul; Rengasamy Palanivel; Ruby L C Hoo; Ruth Isserlin; Gary D Bader; Rungsunn Tungtrongchitr; Yves Deshaies; Aimin Xu; Gary Sweeney
Journal:  Biochem J       Date:  2015-04-27       Impact factor: 3.857

9.  Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery.

Authors:  Lina Zhao; Weidong Chai; Zhuo Fu; Zhenhua Dong; Kevin W Aylor; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  Circ Res       Date:  2013-03-04       Impact factor: 17.367

Review 10.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.